Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan-From the CREDO-Kyoto Registry Cohort-2 and Cohort-3

被引：2

作者：

Natsuaki, Masahiro ^{[1
]}

Morimoto, Takeshi ^{[2
]}

Shiomi, Hiroki ^{[3
]}

Yamamoto, Ko ^{[3
]}

Yamaji, Kyohei ^{[4
]}

Watanabe, Hirotoshi ^{[3
]}

Uegaito, Takashi ^{[5
]}

Matsuda, Mitsuo ^{[5
]}

Tamura, Toshihiro ^{[6
]}

Taniguchi, Ryoji ^{[7
]}

Inoko, Moriaki ^{[8
]}

Mabuchi, Hiroshi ^{[9
]}

Takeda, Teruki ^{[9
]}

Domei, Takenori ^{[4
]}

Shirotani, Manabu ^{[10
]}

Ehara, Natsuhiko ^{[11
]}

Eizawa, Hiroshi ^{[12
]}

Ishii, Katsuhisa ^{[13
]}

Tanaka, Masaru ^{[14
]}

Inada, Tsukasa ^{[14
]}

Onodera, Tomoya ^{[15
]}

Nawada, Ryuzo ^{[15
]}

Shinoda, Eiji ^{[16
]}

Yamada, Miho ^{[16
]}

Yamamoto, Takashi ^{[17
]}

Sakai, Hiroshi ^{[17
]}

Toyofuku, Mamoru ^{[18
]}

Tamura, Takashi ^{[18
]}

Takahashi, Mamoru ^{[19
]}

Tada, Tomohisa ^{[20
]}

Sakamoto, Hiroki ^{[20
]}

Tada, Takeshi ^{[21
]}

Kaneda, Kazuhisa ^{[3
]}

Miki, Shinji ^{[22
]}

Aoyama, Takeshi ^{[23
]}

Suwa, Satoru ^{[24
]}

Sato, Yukihito ^{[7
]}

Ando, Kenji ^{[4
]}

Furukawa, Yutaka ^{[11
]}

Nakagawa, Yoshihisa ^{[17
]}

Kadota, Kazushige ^{[21
]}

Kimura, Takeshi ^{[3
]}

机构：

[1] Saga Univ, Dept Cardiovasc Med, Saga, Japan

[2] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan

[3] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan

[4] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka, Japan

[5] Kishiwada City Hosp, Dept Cardiol, Kishiwada, Japan

[6] Tenri Hosp, Dept Cardiol, Tenri, Nara, Japan

[7] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Cardiol, Amagasaki, Hyogo, Japan

[8] Kitano Hosp, Dept Cardiol, Osaka, Japan

[9] Koto Mem Hosp, Dept Cardiol, Higashiomi, Japan

[10] Kindai Univ, Dept Cardiol, Nara Hosp, Ikoma, Japan

[11] Kobe City Med Ctr, Dept Cardiovasc Med, Gen Hosp, Kobe, Hyogo, Japan

[12] Kobe City Nishi Kobe Med Ctr, Dept Cardiovasc Med, Kobe, Hyogo, Japan

[13] Kansai Denryoku Hosp, Dept Cardiol, Osaka, Japan

[14] Osaka Red Cross Hosp, Dept Cardiol, Osaka, Japan

[15] Shizuoka City Shizuoka Hosp, Dept Cardiol, Shizuoka, Japan

[16] Hamamatsu Rosai Hosp, Dept Cardiol, Hamamatsu, Shizuoka, Japan

[17] Shiga Univ Med Sci Hosp, Dept Cardiol, Otsu, Shiga, Japan

[18] Japanese Red Cross Wakayama Med Ctr, Dept Cardiol, Wakayama, Japan

[19] Shimabara Hosp, Dept Cardiol, Kyoto, Japan

[20] Shizuoka Prefectural Gen Hosp, Dept Cardiol, Shizuoka, Japan

[21] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama, Japan

[22] Mitsubishi Kyoto Hosp, Dept Cardiol, Kyoto, Japan

[23] Shimada Municipal Hosp, Div Cardiol, Shimada, Japan

[24] Juntendo Univ, Dept Cardiol, Shizuoka Hosp, Izunokuni, Japan

来源：

CIRCULATION JOURNAL | 2022年 / 86卷 / 05期

关键词：

  Coronary artery disease; High bleeding risk; Percutaneous coronary intervention; DUAL ANTIPLATELET THERAPY; BARE-METAL; CARDIOVASCULAR EVENTS; STENT; CLOPIDOGREL; MONOTHERAPY; TICAGRELOR; TRENDS;

D O I：

10.1253/circj.CJ-21-0526

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Optimal intensity is unclear for P2Y12 receptor blocker therapy after percutaneous coronary intervention (PCI) in realMethods and Results: From the CREDO-Kyoto Registry, the current study population consisted of 25,419 patients (Cohort-2: n=12,161 and Cohort-3: n=13,258) who underwent their first PCI. P2Y12 receptor blocker therapies were reduced dose of ticlopidine (200 mg/day), and global dose of clopidogrel (75 mg/day) in 87.7% and 94.8% of patients in Cohort-2 and Cohort-3, respectively. Cumulative 3-year incidence of GUSTO moderate/severe bleeding was significantly higher in Cohort-3 than in Cohort-2 (12.1% and 9.0%, P<0.0001). After adjusting 17 demographic factors and 9 management factors potentially related to the bleeding events other than the type of P2Y12 receptor blocker, the higher bleeding risk in Cohort-3 relative to Cohort-2 remained significant (hazard ratio (HR): 1.52 95% confidence interval (CI) 1.37-1.68, P<0.0001). Cohort-3 compared with Cohort-2 was not associated with lower adjusted risk for myocardial infarction/ischemic stroke (HR: 0.96, 95% CI: 0.87-1.06, P=0.44). Conclusions: In this historical comparative study, Cohort-3 compared with Cohort-2 was associated with excess bleeding risk, which might be at least partly explained by the difference in P2Y12 receptor blockers.

引用

页码：748 / +

页数：30

共 50 条

[11] Impact of Renal Dysfunction on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Who Have Concomitant Atrial Fibrillation: From the CREDO-Kyoto Registry Cohort-2
Goto, Koji
Shizuta, Satoshi
Nakai, Kentaro
Morimoto, Takeshi
Shiomi, Hiroki
Natsuaki, Masahiro
Nakagawa, Yoshihisa
Furukawa, Yutaka
Kimura, Takeshi
CIRCULATION, 2013, 128 (22)
[12] Effects of Body Weight on Bleeding and Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-2-
Yamamoto, Ko
Natsuaki, Masahiro
Yoshikawa, Yusuke
Morimoto, Takeshi
Shiomi, Hiroki
Watanabe, Hirotoshi
Kato, Takao
Saito, Naritatsu
Kadota, Kazushige
Ando, Kenji
Furukawa, Yutaka
Tamura, Toshihiro
Sakamoto, Hiroki
Toyofuku, Mamoru
Inada, Tsukasa
Inoko, Moriaki
Suwa, Satoru
Onodera, Tomoya
Ishii, Katsuhisa
Kanamori, Norio
Kimura, Takeshi
CIRCULATION JOURNAL, 2020, 84 (10) : 1734 - +
[13] Effect of statin therapy on cardiovascular outcomes after coronary revascularization in patients ≥80 years of age: Observations from the CREDO-Kyoto Registry Cohort-2
Natsuaki, Masahiro
Morimoto, Takeshi
Furukawa, Yutaka
Shiomi, Hiroki
Ono, Koh
Kimura, Takeshi
ATHEROSCLEROSIS, 2014, 237 (02) : 821 - 828
[14] Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2)
Watanabe, Hiroki
Shiomi, Hiroki
Morimoto, Takeshi
Furukawa, Yutaka
Nakagawa, Yoshihisa
Ando, Kenji
Kadota, Kazushige
Tazaki, Junichi
Watanabe, Hirotoshi
Natsuaki, Masahiro
Minatoya, Kenji
Hanyu, Michiya
Komiya, Tatsuhiko
Kimura, Takeshi
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (01) : 42 - 51
[15] Five-Year Outcomes of Percutaneous Versus Surgical Coronary Revascularization in Patients With Diabetes Mellitus (from the CREDO-Kyoto PCI/CABG Registry Cohort-2)
Marui, Akira
Kimura, Takeshi
Nishiwaki, Noboru
Mitsudo, Kazuaki
Komiya, Tatsuhiko
Hanyu, Michiya
Shiomi, Hiroki
Tanaka, Shiro
Sakata, Ryuzo
AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (08): : 1063 - 1072
[16] Antiplatelet Therapy Discontinuation and the Risk of Serious Cardiovascular Events after Coronary Stenting: Observations from the CREDO-Kyoto Registry Cohort-2
Watanabe, Hirotoshi
Morimoto, Takeshi
Natsuaki, Masahiro
Furukawa, Yutaka
Nakagawa, Yoshihisa
Kadota, Kazushige
Yamaji, Kyohei
Ando, Kenji
Shizuta, Satoshi
Shiomi, Hiroki
Tada, Tomohisa
Tazaki, Junichi
Kato, Yoshihiro
Hayano, Mamoru
Abe, Mitsuru
Tamura, Takashi
Shirotani, Manabu
Miki, Shinji
Matsuda, Mitsuo
Takahashi, Mamoru
Ishii, Katsuhisa
Tanaka, Masaru
Aoyama, Takeshi
Doi, Osamu
Hattori, Ryuichi
Kato, Masayuki
Suwa, Satoru
Takizawa, Akinori
Takatsu, Yoshiki
Shinoda, Eiji
Eizawa, Hiroshi
Takeda, Teruki
Lee, Jong-Dae
Inoko, Moriaki
Ogawa, Hisao
Hamasaki, Shuichi
Horie, Minoru
Nohara, Ryuji
Kambara, Hirofumi
Fujiwara, Hisayoshi
Mitsudo, Kazuaki
Nobuyoshi, Masakiyo
Kita, Toru
Kastrati, Adnan
Kimura, Takeshi
PLOS ONE, 2015, 10 (04):
[17] Renal Function and Effect of Statin Therapy on Cardiovascular Outcomes in Patients Undergoing Coronary Revascularization: An observation from the CREDO-Kyoto Registry Cohort-2
Natsuaki, Masahiro
Furukawa, Yutaka
Morimoto, Takeshi
Kimura, Takeshi
CIRCULATION, 2012, 126 (21)
[18] Three-year Clinical Outcomes in Patients with Polyvascular Disease Undergoing Coronary Revascularization: A Report from the CREDO-Kyoto Registry Cohort-2
Morikami, Yuko
Natsuaki, Masahiro
Morimoto, Takeshi
Kimura, Takeshi
CIRCULATION, 2012, 126 (21)
[19] Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Corners Registry of Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-3-
Natsuaki, Masahiro
Morimoto, Takeshi
Shiomi, Hiroki
Ehara, Natsuhiko
Taniguchi, Ryoji
Tamura, Toshihiro
Tada, Takeshi
Suwa, Satoru
Kaneda, Kazuhisa
Watanabe, Hirotoshi
Tazaki, Junichi
Watanabe, Shin
Yamamoto, Erika
Saito, Naritatsu
Fuki, Masayuki
Takeda, Teruki
Eizawa, Hiroshi
Shinoda, Eiji
Mabuchi, Hiroshi
Shirotani, Manabu
Uegaito, Takashi
Matsuda, Mitsuo
Takahashi, Mamoru
Inoko, Moriaki
Tamura, Takashi
Ishii, Kazuhisa
Onodera, Tomoya
Sakamoto, Hiroki
Aoyama, Takeshi
Sato, Yukihito
Ando, Kenji
Furukawa, Yutaka
Nakagawa, Yoshihisa
Kadota, Kazushige
Kimura, Takeshi
CIRCULATION JOURNAL, 2021, 85 (06) : 769 - +
[20] Renal Function and Effect of Statin Therapy on Cardiovascular Outcomes in Patients Undergoing Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-2)
Natsuaki, Masahiro
Furukawa, Yutaka
Morimoto, Takeshi
Sakata, Ryuzo
Kimura, Takeshi
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (11): : 1568 - 1577

← 1 2 3 4 5 →